
Prof. Dr. Necdet Üskent, MD
Medical Oncology
Since 2005, he has been serving as a medical oncology and hematology specialist, as well as the coordinator of oncological sciences at Anadolu Medical Center.
EDUCATION
University
University of Ankara School of Medicine, 1971
Residency
GATA, Internal Medicine, 1975-1979
Fellowship
University of Texas, Hematology & Oncology, 1979-1982
Other
University of London Charing Cross Hospital-UK, Bone Marrow Transplantation, 1986 April-October (6 months)
University of Basel, Kantonsspital Basel-Switzerland, Loco-regional Chemotherapy, 1989 September-January (3 months)
University of London, Royal Free Hospital, Stem Cell Transplantation, 1998
BOARD CERTIFICATION
Internal Medicine, 1979
Medical Oncology, 1983
Hematology, 1983
MEDICAL LICENSURE
Texas license - licence number: G 1791
Georgia licence – licence number: 22971
ESMO Medical oncology certificate – certificate number: 258-495-1
PREVIOUS PROFESSIONAL POSITIONS
1982-1984 Assistant Professor of Internal Medicine, GATA Department of Internal Medicine
1984-1989 Associate Professor of Internal Medicine, GATA Department of Internal Medicine, Division of Medical Oncology
1989-2001 Professor of Internal Medicine, GATA Department of Internal Medicine-Director- Chief of Hematology &Oncology Department
2001-2006 2001-2006 Professor of Internal Medicine, Kadir Has University School of Medicine Chief of Internal Medicine Department
EDUCATION—TEACHING
Medical School: GATA School of Medicine: Classes 3 , 4 and 6, 1984-2001
University of Marmara School of Medicine: Classes 3 and 4,1987-1990
Kadir Has University, School of Medicine: Classes 3 and 4, 2001-2006 Graduate School: Istanbul University Çapa Institute of Oncology, Courses for Doctorate Students, 1990-1992
Continuing Education: ESMO Courses in Antalya, Istanbul, and Ankara Medical Oncology Courses in National Cancer Congresses New Trends in Oncology-Istanbul, 2008 and 2009
EDUCATION—JOURNALS
Member of Editorial Board and Reviewer of
· Journal of Hematology and Oncology (Turkey),
· Cancer (Turkey),
· Journal of Oncology (Turkey),
· New Drugs (International)
MEMBERSHIPS
ASCO (American Society of Clinical Oncology)
ESMO (European Society of Medical Oncology)
National Society of Medical Oncology
Turkish Associaton of Hematology
INVITED VISITING PROFESSORSHIPS
University of London, Charing Cross and Westminster Medical School,1986
University of London Royal Free Hospital, 1998
PRESENTATIONS AT NATIONAL MEETINGS
More than 200 Oral Presentations in National Meetings*
PRESENTATIONS AT INTERNATIONAL MEETINGS
More than 100 abstracts and oral presentations in International Cogresses *
INTRAMURAL PRESENTATIONS
Oncology Board, Grand Rounds and Journal Clubs weekly
CLINICAL PRACTICE, INTERESTS, AND ACCOMPLISHMENTS
Breast cancer, Lung cancer, Gastrointestinal Cancers,Lymphoma, Melanoma, Myeloma, Cancer Vaccines and Targeted therapies
RESEARCH INTERESTS
Cancer Vaccines and Gene Therapies
International Multi-National Multicentric and National Multicentric Phase 3 Studies:
ISEL Study: Gefitinib in Placebo randomised double blind phase III study in Previously Treated Resistent or Progressive Non-Small Cell Lung Cancer, 2004
Efficacy of Docataxel as a First Line Single Agent Compare to Docataxel+ Cisplatin in Stage III/IV Non-Small Cell Lung Cancer, Phase III, Randomised Study, 2000
Florourasil+ Leucovorine vs Florourasil+ alpha Inteferon in metastatic Colorectal cancer, Phase III, Randomised Study, 1999
Neoadjuvant FOLFIRI vs FOLFOX in the resectability of liver metastases in colo-rectal cancer,Randomized National Multicentric Study
Anastrozol Farmacovijilans Study in Early Postmenapausal Breast Cancer Patients,in Turkey. Multicentric National Study (Coordinator), 2008
Interferon Maintenance in Multiple Myeloma patients in plato phase, multinational, multicentric study, 1997
A Phase III Clinical Trial to Evaluate the safety and Efficacy of Treatment with 2 mg Intralesional Allovectin-7. Compared to Dacarbazine(DTIC) or Temozolamide (TMZ) in Subjects with Recurren Metastatic Melanoma Randomized 2010
BIBLIOGRAPHY
More than 200 published articles in National and Internatinal Journals*